A Santoro

Summary

Affiliation: University of Bologna
Country: Italy

Publications

  1. ncbi request reprint [Should dialysis be for all? Maybe not]
    A Santoro
    U O C di Nefrologia Dialisi Ipertensione, Policlinico S Orsola Malpighi, Bologna, Italy
    G Ital Nefrol 25:284-9. 2008
  2. ncbi request reprint Blood volume regulation during hemodialysis
    A Santoro
    Malpighi Division of Nephrology and Dialysis, Policlinico S Orsola Malpighi, Bologna, Italy
    Am J Kidney Dis 32:739-48. 1998
  3. ncbi request reprint [Automatic system control and its application in dialysis]
    A Santoro
    Divisione di Nefrologia, Dialisi e Ipertensione, Policlinico S Orsola Malpighi, Bologna
    G Ital Nefrol 24:s69-79. 2007
  4. doi request reprint Mars and Prometheus: our clinical experience in acute chronic liver failure
    S Faenza
    Department of Surgery, Intensive Care and Transplantation, Policlinico Sant Orsola, Bologna, Italy
    Transplant Proc 40:1169-71. 2008
  5. ncbi request reprint Acute renal failure after liver transplantation in MELD era
    S Faenza
    Department of Surgery, Intensive Care and Transplantation, University of Bologna, Bologna, Italy
    Transplant Proc 39:1945-6. 2007
  6. ncbi request reprint A prospective randomised European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis
    A Santoro
    Malpighi Hospital, Bologna, Italy
    J Nephrol 12:375-82. 1999
  7. ncbi request reprint Confounding factors in the assessment of delivered hemodialysis dose
    A Santoro
    Malpighi Nephrology and Dialysis Division, Policlinico S Orsola Malpighi, Bologna, Italy
    Kidney Int Suppl 76:S19-27. 2000
  8. doi request reprint Efficacy and (pharmaco)kinetics of one single dose of rasburicase in patients with chronic kidney disease
    E Sestigiani
    Department of Nephrology, Dialysis and Hypertension, Malpighi Hospital, Bologna, Italy
    Nephron Clin Pract 108:c265-71. 2008
  9. ncbi request reprint Anemia and erythropoietin treatment in chronic kidney diseases
    A Santoro
    Unit of Nephrology and Dialysis, Policlinico S Orsola Malpighi, Bologna, Italy
    Minerva Urol Nefrol 57:23-31. 2005
  10. ncbi request reprint [Cardiac arrhythmias in patients with renal insufficiency treated with periodic hemodialysis]
    A Santoro
    Unita Operativa Complessa di Nefrologia e Dialisi, Policlinico S Orsola Malpighi, Bologna
    G Ital Nefrol 23:552-9. 2006

Detail Information

Publications54

  1. ncbi request reprint [Should dialysis be for all? Maybe not]
    A Santoro
    U O C di Nefrologia Dialisi Ipertensione, Policlinico S Orsola Malpighi, Bologna, Italy
    G Ital Nefrol 25:284-9. 2008
    ....
  2. ncbi request reprint Blood volume regulation during hemodialysis
    A Santoro
    Malpighi Division of Nephrology and Dialysis, Policlinico S Orsola Malpighi, Bologna, Italy
    Am J Kidney Dis 32:739-48. 1998
    ....
  3. ncbi request reprint [Automatic system control and its application in dialysis]
    A Santoro
    Divisione di Nefrologia, Dialisi e Ipertensione, Policlinico S Orsola Malpighi, Bologna
    G Ital Nefrol 24:s69-79. 2007
    ..These systems include biofeedback control of blood volume, biofeedback control of thermal balance, and biofeedback control of blood pressure...
  4. doi request reprint Mars and Prometheus: our clinical experience in acute chronic liver failure
    S Faenza
    Department of Surgery, Intensive Care and Transplantation, Policlinico Sant Orsola, Bologna, Italy
    Transplant Proc 40:1169-71. 2008
    ..In our clinical context, there are two groups that practice blood purification treatments on acute or chronic liver failure (AoCLF) patients: one group used MARS (molecular adsorbent recirculating system) and the other Prometheus...
  5. ncbi request reprint Acute renal failure after liver transplantation in MELD era
    S Faenza
    Department of Surgery, Intensive Care and Transplantation, University of Bologna, Bologna, Italy
    Transplant Proc 39:1945-6. 2007
    ..001), and blood transfusion rates (P < .05) as well as intraoperative diuresis (P < .05). In our analysis we did not observe a correlation between MELD score and postoperative ARF...
  6. ncbi request reprint A prospective randomised European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis
    A Santoro
    Malpighi Hospital, Bologna, Italy
    J Nephrol 12:375-82. 1999
    ..Mortality, morbidity both in terms of intra- and interdialysis symptoms - and hospitalisation rate, as well as the patients' quality of life, evaluated by the SF36 questionnaire, will be analysed...
  7. ncbi request reprint Confounding factors in the assessment of delivered hemodialysis dose
    A Santoro
    Malpighi Nephrology and Dialysis Division, Policlinico S Orsola Malpighi, Bologna, Italy
    Kidney Int Suppl 76:S19-27. 2000
    ....
  8. doi request reprint Efficacy and (pharmaco)kinetics of one single dose of rasburicase in patients with chronic kidney disease
    E Sestigiani
    Department of Nephrology, Dialysis and Hypertension, Malpighi Hospital, Bologna, Italy
    Nephron Clin Pract 108:c265-71. 2008
    ..We studied the pharmacokinetics and metabolism of rasburicase in the treatment of chronic asymptomatic hyperuricemia in chronic kidney disease (CKD) patients...
  9. ncbi request reprint Anemia and erythropoietin treatment in chronic kidney diseases
    A Santoro
    Unit of Nephrology and Dialysis, Policlinico S Orsola Malpighi, Bologna, Italy
    Minerva Urol Nefrol 57:23-31. 2005
    ..The hemoglobin concentration target in pre-dialysis and dialysis patients is the subject of continuous re-assessment...
  10. ncbi request reprint [Cardiac arrhythmias in patients with renal insufficiency treated with periodic hemodialysis]
    A Santoro
    Unita Operativa Complessa di Nefrologia e Dialisi, Policlinico S Orsola Malpighi, Bologna
    G Ital Nefrol 23:552-9. 2006
    ....
  11. ncbi request reprint Prometheus system: a technological support in liver failure
    A Santoro
    Operative Unit of Nephrology, Dialysis and Hypertension, Department of Nephrology and Urology, Sant Orsola Malpighi Hospital, Bologna, Italy
    Transplant Proc 38:1078-82. 2006
    ..The overall survival at 30 days was 41.6% (5/12 patients). Prometheus, based on FPSA, produced high clearance for protein-bound and water soluble markers, which resulted in high treatment efficacy...
  12. ncbi request reprint [Epidemiology of acute renal failure]
    A Santoro
    U O Nefrologia, Dialisi, Ipertensione, Policlinico S Orsola Malpighi, Bologna
    G Ital Nefrol 23:S3-12. 2006
    ..Finally, some unfavorable prognostic factors include the prolonged use of high dose inotropic drugs, mechanical ventilation, cardiac failure and a septic state...
  13. ncbi request reprint Dry weight in hemodialysis: volemic control
    P Zucchelli
    Malpighi Department of Nephrology, Policlinico S Orsola Malpighi, Bologna, Italy
    Semin Nephrol 21:286-90. 2001
    ..The biofeedback system, exploiting the automatic control of the intradialytic variations, may represent an additional advantage in the formulation of an ideal postdialysis blood volume that overlaps the patient's dry weight...
  14. ncbi request reprint Electrophysiological response to dialysis: the role of dialysate potassium content and profiling
    A Santoro
    Malpighi Nephrology Division, Policlinico S Orsola Malpighi, Bologna, Italy
    Contrib Nephrol 149:295-305. 2005
    ..53 +/- 13 AFBK). Moreover, in the most arrhythmic patients the benefit accruing from the smooth K+ removal rate was more pronounced (103 +/- 19 in AFB vs. 78 +/- 13 in AFBK)...
  15. ncbi request reprint Mid-dilution: the perfect balance between convection and diffusion
    A Santoro
    UO Nefrologia e Dialisi Malpighi, Policlinico S Orsola Malpighi, Bologna, Italy
    Contrib Nephrol 149:107-14. 2005
    ..MD HDF supports substantially higher ultrafiltration rates, and as such, results in a higher removal of middle-molecular-weight toxins...
  16. ncbi request reprint Online convective therapies: results from a hemofiltration trial
    A Santoro
    UO Nefrologia e Dialisi Malpighi, Policlinico S Orsola Malpighi, Bologna, Italy
    Contrib Nephrol 149:51-7. 2005
    ..By the end of the protocol, patients in HF showed a 2.5% incidence of acute dialysis hypotension, while patients in BD had 23%...
  17. ncbi request reprint The kidney in hepatorenal syndrome (I Part)
    A Santoro
    Nephrology and Dialysis Unit, Policlinico Sant Orsola Malpighi, Bologna, Italy
    Int J Artif Organs 27:95-103. 2004
  18. ncbi request reprint Surgical exposure of lateral orbital lesions using a coronal scalp flap and lateral orbitozygomatic approach: clinical experience
    S Paolini
    Universita degli Studi di Perugia, Cattedra di Neurochirurgia IRCCS Neuromed, Pozzilli, Italy
    Acta Neurochir (Wien) 148:959-63. 2006
    ..The procedure was intended to overcome the potential drawbacks associated with the classic transtemporal approach...
  19. ncbi request reprint Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation
    S Faenza
    Dipartimento di Discipline Chirurgiche, Rianimatorie e dei Trapianti, Rianimatorie e dei Trapianti, Italy
    Transplant Proc 38:1141-2. 2006
    ....
  20. ncbi request reprint [Census 2004 of the Italian Renal and Dialysis Units. Emilia-Romagna, Toscana]
    T Lusenti
    UO di Nefrologia e Dialisi, Ospedale S Maria Nuova, Reggio Emilia, Italy
    G Ital Nefrol 23:203-11. 2006
    ..7 and 3.3 dialysis patients. E) Activity: hospital admissions 1572, 1769 pmp; renal biopsies 115 and 166 pmp...
  21. ncbi request reprint Chronic expanding intracerebral hematoma treated by mini-invasive ultrasonography-guided needle aspiration
    E Passacantilli
    Department of Neuroscience Neurosurgery, University of Rome La Sapienza, Rome, Italy
    J Neurosurg Sci 50:67-70. 2006
    ..US-guided aspiration is a low cost, not time consuming technique, that allows an intraoperative real-time control of the lesion and seems to be an effective alternative to open surgery in cases of CEIHs with a thin capsule...
  22. ncbi request reprint Adenosine kinase from rat liver: new biochemical properties
    R Leoncini
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry University of Siena, Siena, Italy
    Nucleosides Nucleotides Nucleic Acids 25:1107-12. 2006
    ..Cells could exploited this property in situations in which ATP levels are strongly decreased and ADP decreases slowly...
  23. doi request reprint A kinetic study of the rat liver adenosine kinase reverse reaction
    D Vannoni
    Dipartimento di Medicina Interna, Sc Endocrino Metaboliche e Biochimica, Universita di Siena, Siena, Italy
    Nucleosides Nucleotides Nucleic Acids 27:872-5. 2008
    ..This reaction could be used by cells under particular conditions of energy deficiency and, together with myokinase activity, may help to restore physiological ATP levels...
  24. doi request reprint Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
    P A Zucali
    Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Milan, Italy
    Ann Oncol 19:1605-12. 2008
    ..However, resistance mechanisms are not well understood. We evaluated several potential biological markers of intrinsic EGFR-TKIs-resistance in NSCLC...
  25. ncbi request reprint [Salivary analyses for biologic monitoring: possibility and perspectives]
    L Caporossi
    ISPESL, Dipartimento di Medicina del Lavoro, Centro Ricerche Monteporzio Catone, RM
    G Ital Med Lav Ergon 29:532-4. 2007
    ..This approach appears to offer a wide range of applications, and certainly merits further study...
  26. ncbi request reprint EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
    F Cappuzzo
    Department of Medical Oncology, Istituto Clinico Humanitas IRCCS, Rozzano, Italy
    Ann Oncol 19:717-23. 2008
    ..Standardized conditions to distinguish subpopulations of colorectal cancer (CRC) patients more and less sensitive to cetuximab therapy remain undefined...
  27. ncbi request reprint IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients
    M Magagnoli
    Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Milan, Italy
    Bone Marrow Transplant 40:1019-25. 2007
    ..Thirty-four patients received a single and 47 received tandem transplantation with rapid engraftment. These results confirm that the IGEV regimen with lenograstim support can be used successfully and safely to mobilize PBSCs...
  28. ncbi request reprint An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
    E Van Cutsem
    Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium
    Ann Oncol 19:92-8. 2008
    ....
  29. doi request reprint Sorafenib in advanced hepatocellular carcinoma
    Josep M Llovet
    Barcelona Clinic Liver Cancer Group, Institut d Investigacions Biomediques August Pi i Sunyer, Centro de Investigaciones en Red de Enfermedades Hepáticas y Digestivas Hospital Clínic Barcelona, Barcelona
    N Engl J Med 359:378-90. 2008
    ..A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in hepatocellular carcinoma...
  30. ncbi request reprint Inhibition of chronic graft-vs-host disease with retention of anti-myeloma effects by the proteasome inhibitor bortezomib
    E Todisco
    Leuk Lymphoma 48:1015-8. 2007
  31. ncbi request reprint Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib
    F Cappuzzo
    University of Colorado Cancer Center, Department of Medicine Medical Oncology and Pathology, Aurora, USA
    Ann Oncol 17:1120-7. 2006
    ..The aim of the study was to assess whether loss of PTEN and expression of insulin-like growth factor receptor 1 (IGFR-1) could be responsible for intrinsic resistance to the tyrosine kinase inhibitor (TKI) gefitinib...
  32. ncbi request reprint Vasospasm of venous grafts in extra-intracranial by-pass. Report of two cases
    A Santoro
    Department of Neurosurgical Sciences, Neurosurgery I, University of Rome La Sapienza, Rome, Italy
    J Neurosurg Sci 49:107-15; discussion 115. 2005
    ..Spasm of the venous graft, a well-known occurrence in cardiac revascularization, can also be observed in cerebral revascularization...
  33. ncbi request reprint Intensive care complications in liver and multivisceral transplantation
    S Faenza
    Department of Surgery, Intensive Care and Transplantation, University of Bologna, Bologna, Italy
    Transplant Proc 37:2618-21. 2005
    ....
  34. ncbi request reprint High rate of remission and low rate of disease recurrence in patients with multiple myeloma allografted with PBSC from their HLA-identical sibling donors
    I Majolino
    Hematology and Bone Marrow Transplantation Unit, Azienda Ospedaliera S Camillo Forlanini, Roma, Italy
    Bone Marrow Transplant 31:767-73. 2003
    ..PBSC allograft can induce long remissions, because of profound suppression of the neoplastic clone that is probably linked to the antitumor effect of cGVHD...
  35. ncbi request reprint Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas
    L Castagna
    Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Milan, Italy
    Bone Marrow Transplant 30:207-14. 2002
    ..Our study confirms that a low intensity conditioning regimen for allogeneic stem cell transplantation is feasible and effective in heavily pretreated patients...
  36. ncbi request reprint Irinotecan and raltitrexed: an active combination in advanced colorectal cancer
    C Carnaghi
    Medical Oncology and Haematology Department, Istituto Clinico Humanitas, Milan, Italy
    Ann Oncol 13:1424-9. 2002
    ..The aim of our phase II trial was to assess the efficacy and tolerability of the combination of irinotecan and raltitrexed in patients with metastatic colorectal cancer untreated with chemotherapy...
  37. ncbi request reprint Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide
    M Balzarotti
    Department of Medical Oncology and Hematology, and Division of Pathology, Istituto Clinico Humanitas, Rozzano Milano, Italy
    Ann Oncol 13:1341-6. 2002
    ....
  38. ncbi request reprint Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study
    H Soto Parra
    Department of Medical Oncology and Hematology and Division of Thoracic Surgery, Istituto Clinico Humanitas, Rozzano Milan, Italy
    Ann Oncol 13:1080-6. 2002
    ..We therefore started a randomized phase II trial to compare toxicity and dose intensity (DI) between these two GC schedules...
  39. ncbi request reprint Discontinuous myelotomy: an alternative to standard myelotomy in the surgical treatment of intramedullary spinal cord tumours
    G Cantore
    Department of Neurosciences, University of Rome La Sapienza I Chair of Neurosurgery, Rome, Italy
    Acta Neurochir (Wien) 144:373-6. 2002
    ..We developed a technique of discontinuous myelotomy to preserve the integrity of these large spinal cord vessels...
  40. ncbi request reprint Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients
    G Minniti
    Division of Neurosurgery, IRCCS NEUROMED University of Rome, Pozzilli, Italy
    Acta Neurochir (Wien) 143:1205-11. 2001
    ..We conclude that transsphenoidal surgery, if well planned and carefully performed, is safe and able to induce a significant cardiovascular and metabolic improvement even in elderly acromegalic patients...
  41. ncbi request reprint Continuous urea monitoring in hemodialysis: a model approach to forecast dialytic performance. Results of a multicenter study
    G Arrigo
    Division of Nephrology, San Carlo Borromeo Hospital, Milan, Italy
    J Nephrol 14:481-7. 2001
    ..The comparison between the prediction errors in the two treatments were not statistically significant. The recirculation measurement would probably reduce the bias if it were properly incorporated into the model...
  42. ncbi request reprint Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients
    G Minniti
    Neuromed, IRCCS (Pozzilli, Rome, Italy
    Clin Endocrinol (Oxf) 55:307-13. 2001
    ..CONCLUSIONS: We conclude that successful transsphenoidal surgery is able to induce a significant improvement in some cardiac parameters and a slight reduction in systolic blood pressure in acromegalic patients...
  43. ncbi request reprint Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
    A Santoro
    Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Milan, Italy
    Ann Oncol 15:33-7. 2004
    ..Therefore, we aimed to assess the antitumor activity and tolerability of gefitinib in a series of patients with previously treated, advanced NSCLC, as a part of a compassionate use program...
  44. ncbi request reprint Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature
    G Minniti
    Department of Neurological Sciences, Neuromed Institute, RCSS, Via Atinense 18, 86077 Pozzili IS, Italy
    Endocr Relat Cancer 10:611-9. 2003
    ..We conclude that TSS is able to achieve a biochemical remission in more than half of acromegalic patients, and that the current criteria for remission seem to indicate a cure in most cases...
  45. pmc Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
    P F Conte
    Department of Medical Oncology and Hematology, University of Modena and Reggio Emilia, Italy
    Br J Cancer 93:406-11. 2005
    ..The gemcitabine, epirubicin, taxol regimen is active and well tolerated as PCT for operable breast cancer. This combination allows the administration of full doses of active agents with a low incidence of febrile neutropenia...
  46. ncbi request reprint BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: a phase II study group trial of the Central European Society of Anticancer-Drug Research (CESAR)
    R D Hofheinz
    Onkologisches Zentrum, III Medizinische Klinik, Fakultät für Klinische Medizin Mannheim, Universitat Heidelberg, Germany
    Invest New Drugs 23:363-8. 2005
    ..In terms of antitumor activity, BBR 3438 was found to be ineffective in the treatment of gastric cancer...
  47. ncbi request reprint [Guidelines on water and solutions for dialysis. Italian Society of Nephrology]
    S Alloatti
    Center for Nephrology and Dialysis of Aosta, Italian Society of Nephrology, Aosta, Italy
    G Ital Nefrol 22:246-73. 2005
    ..Suggestions and questions concerning these guidelines are welcome to nefrologia@sin-italy.org...
  48. ncbi request reprint [Hypertension, atherosclerosis and kidney]
    A Zuccala
    U O Nefrologia Malpighi, Policlinico S Orsola Malpighi, Bologna, Italy
    G Ital Nefrol 22:S9-14. 2005
    ..Finally, it is important to consider that the kidney, being an organ with a wide vasculature, could be a sophisticated sensor of subclinical cardiovascular damage...
  49. ncbi request reprint [Arterial hypertension and cardiovascular risk in patients with nephropathy]
    A Santoro
    U O Nefrologia Malpighi, Policlinico S Orsola Malpighi, Bologna Italy
    G Ital Nefrol 22:S56-9. 2005
    ..Control that to judge from the various studies published to date, appears to be far from easy to implement in clinical practice, and above all in dialysis...
  50. ncbi request reprint [Italian Registry of Dialysis and Transplantation: 1996-2001 experience]
    F Conte
    G Ital Nefrol 21:561-7. 2004
    ..The gross mortality rate in dialyzed patients was stable during this period, at approximately 14%, the main causes of death being cardiovascular diseases and cachexia...
  51. ncbi request reprint Extracorporeal support of liver function (II part)
    A Santoro
    Unit of Nephrology and Dialysis, Department of Nephrology and Urology, Policlinico Sant Orsola Malpighi, Bologna, Italy
    Int J Artif Organs 27:176-85. 2004
  52. ncbi request reprint Role of intensive therapy in liver transplant recipients: experience in blood purification and biosynthetic techniques
    S Faenza
    Department of Surgery, University of Bologna, Bologna, Italy
    Transplant Proc 36:555-7. 2004
    ..The aim of this work was to provide a summary of our clinical findings and current methods in extracorporeal liver support with the goal of improving the clinical status potential transplant patients...
  53. ncbi request reprint Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer
    M Magagnoli
    Bone Marrow Transplant 33:1261-2. 2004
  54. ncbi request reprint Pilot study with adriamycin and ifosfamide in small cell lung cancer
    P Bidoli
    Division of Medical Oncology, Istituto Nazionale Tumori, Milano, Italy
    Tumori 75:34-7. 1989
    ..However, the high response rate achieved after four cycles and the low incidence of marrow toxicity suggest the use of this regimen for a short period with increased dose levels...